APA

Baselga J., Gelmon K. A., Verma S., Wardley A., Conte P., Miles D., Bianchi G., Cortes J., McNally V. A., Ross G. A., Fumoleau P. & Gianni L. (20100325). Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Baselga José, Gelmon Karen A, Verma Shailendra, Wardley Andrew, Conte Pierfranco, Miles David, Bianchi Giulia, Cortes Javier, McNally Virginia A, Ross Graham A, Fumoleau Pierre and Gianni Luca. 20100325. Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Baselga J., Gelmon K. A., Verma S., Wardley A., Conte P., Miles D., Bianchi G., Cortes J., McNally V. A., Ross G. A., Fumoleau P. and Gianni L. (20100325). Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Baselga José, Gelmon Karen A, Verma Shailendra, Wardley Andrew, Conte Pierfranco, Miles David, Bianchi Giulia, Cortes Javier, McNally Virginia A, Ross Graham A, Fumoleau Pierre and Gianni Luca. Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20100325.